Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Androgens may block hair growth signals, targeting this could treat hair loss.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Men have more severe COVID-19 outcomes than women.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Hair loss gene found on chromosome 3q26.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Adrenal disorders can cause lasting brain and behavior issues in children.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Pharmacists play a crucial role in improving patient outcomes through personalized care and staying updated with scientific advancements.

Fetal environments contain various chemicals that may disrupt hormones.

Lifestyle changes can help manage androgenetic alopecia.

Ayurvedic plants may help treat PCOD by affecting hormones and ovarian health.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

The formulated gel is a promising treatment for alopecia areata.